Skip to main content

Table 5 CAR-NK cells in clinical trials

From: NK cell upraise in the dark world of cancer stem cells

Tumor type

Condition or disease

Origin of NK cell

Target

Status

Phase

Country

Clinical trial ID

Hematological malignancy

B-ALL

Haploidentical PB-NK

CD19

Recruiting

II

Singapore

NCT01974479

B-ALL

Haploidentical PB-NK

CD19

Completed

I

USA

NCT00995137

Lymphoma and leukaemia

NK-92

CD7

Recruiting

I/II

China

NCT02742727

Lymphoma and leukaemia

NK-92

CD19

Recruiting

I/II

China

NCT02892695

Refractory B-cell lymphoma

Unknown

CD19

Not recruiting

Early I

China

NCT03690310

Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Unknown

CD19

Not recruiting

Early Phase 1

China

NCT04639739

Relapsed and refractory B cell malignancies

Unknown

 

Recruiting

I/II

China

NCT04747093

Refractory B-cell lymphoma

Unknown

CD19/CD22

not recruiting

Early I

China

NCT03824964

AML

NK-92

CD33

Completed

I/II

China

NCT02944162

Lymphoma and leukaemia (relapsed/refractory B-cell malignancy)

Umbilical cord blood

CD19

Recruiting

I/II

USA

NCT03056339

Refractory B-cell lymphoma

Unknown

CD22

Not recruiting

Early I

China

NCT03692767

Lymphoma and leukaemia

Umbilical cord blood

CD19

Withdrawn

I/II

USA

NCT03579927

relapsed/refractory multiple myeloma

NK92

BCMA

Recruiting

I/II

China

NCT03940833

B-cell lymphoma, CLL

iPSC (FT596)

CD19

Recruiting

I

USA

NCT04245722

Solid tumor

Metastatic solid tumor

PB-NK

NKG2DL

Recruiting

I

China

NCT03415100

Glioblastoma

NK-92

HER2

Recruiting

I

Germany

NCT03383978

Non-small cell lung cancer

NK-92

–

Recruiting

I

China

NCT03656705

Solid tumor

NK-92

ROBO1

Recruiting

I/II

China

NCT03931720

Solid tumors

NK-92

ROBO1

Recruiting

I/II

China

NCT03940820

Pancreatic cancer

NK-92

ROBO1

Recruiting

I/II

China

NCT03941457

Epithelial ovarian cancer

PB-NK

Mesothelin

not recruiting

Early I

China

NCT03692637

Castration-resistant prostate cancer/

PB-NK

PSMA

Not recruiting

Early I

China

NCT03692663

Solid tumor

NK-92

MUCI

Recruiting

I/II

China

NCT02839954